Entries Categorized as 'Treatment'

PREVENTATIVE BRAIN RADIATION FOR LUNG CANCER

Date November 12, 2009

nospam@example.com (Clear the Smoke) wrote an intriguing post today onHere’s a little tasterA new study is taking a closer look at the benefits versus risks for lung cancer patients to undergo preventative brain radiation therapy as a means to stop cancer from spreading to the brain.
Study results show that while preventative brain radiation for [...]

“The New Face Of Lung Cancer: Personalized Medicine”

Date November 6, 2009

sam wrote an intriguing post today onHere’s a little tasterWinthrop-University Hospital’s Advances in Cancer Care educational series will offer a free program, “The New Face of Lung Cancer: Personalized Medicine,” on Tuesday, November 10, 2009, at 7:00 PM. It will be held at Winthrop’s Community Outreach Center, located at 101 Mineola Boulevard at the [...]

Lung cancer vaccine being tested in Europe

Date August 21, 2009

sam wrote an intriguing post today onHere’s a little tasterA vaccine for lung cancer is being tested in Serbia, which has the highest number of lung cancer patients in Europe.
Read the rest of this post here

Hope for people suffering from lung cancer

Date August 21, 2009

nospam@example.com (Clear the Smoke) wrote an intriguing post today onHere’s a little tasterSerbia is the first country in Europe to test the vaccine against lung cancer. Presently the effects of the vaccine are being tested on four patients at ‘Bezanijska Kosa’ hospital. It is being given to patients after the treatment. They have already [...]

The human placenta releases substances that drive lung cancer into apoptosis

Date August 21, 2009

Debi wrote an intriguing post today onHere’s a little tasterAs there is no optimal treatment of non small cell lung cancer due to its resistance to common chemotherapeutics, we investigated the effect of human placenta-conditioned medium on tumor tissue. The human placenta constitutes a mixture of maternal and fetal origin and displays a variety [...]

Study: Lung cancer pill works for some patients

Date August 19, 2009

nospam@example.com (Clear the Smoke) wrote an intriguing post today onHere’s a little tasterFour years after the government severely restricted its use, the lung cancer drug Iressa may be poised to make a comeback: A study concludes it can slow the deadly disease better than standard chemotherapy in certain patients.
Read the rest of this post [...]

Avastin wows again in breast cancer trial as second-line agent

Date August 19, 2009

Debi wrote an intriguing post today onHere’s a little tasterRoche’s flagship cancer drug Avastin won yet another gold star yesterday after performing well in a late stage trial assessing its potential in extending progression free survival in women with breast cancer.
Currently, the drug is approved on both sides of the Atlantic as a treatment [...]

‘Trojan horse’ drug shows cancer benefit

Date August 11, 2009

Debi wrote a pretty interesting post today onHere’s an excerpt for you A drug that takes advantage of cancer cells’s appetite for the vitamin folate helped keep lung cancer at bay in 30 percent of patients with advanced disease, the chief executive of Endocyte said on Monday.
Read the rest of their post here here [...]

Sirnaomics Receives NCI Grant to Develop siRNA-Based Lung Cancer Rx

Date July 23, 2009

nospam@example.com (Clear the Smoke) wrote a good post today onHere’s a little excerptSirnaomics this week announced that it has received a Small Business Innovation Research grant from the National Cancer Institute to develop novel siRNA-based therapeutics for lung cancer.
Read the rest of this great post here

Drug Combination Helps Patients with Advanced Lung Cancer

Date July 23, 2009

Debi wrote a good post today onHere’s a little excerptA study examining erlotinib-bevacizumab combination therapy in patients with advanced non-small cell lung cancer (NSCLC) suggests that disease progression can be delayed with this therapy.
 
These findings were presented by Vincent Miller, MD at the 2009 Annual Meeting of the American Society of Clinical Oncology.
Read the [...]